| Charles M Biddle Iv, MD | |
|
701 E Main St, Moorestown, NJ 08057-3032 | |
| (856) 727-9907 | |
| (856) 727-9989 |
| Full Name | Charles M Biddle Iv |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 701 E Main St, Moorestown, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265469373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles M Biddle Iv, MD 701 E Main St, Moorestown, NJ 08057-3032 Ph: (856) 727-9907 | Charles M Biddle Iv, MD 701 E Main St, Moorestown, NJ 08057-3032 Ph: (856) 727-9907 |
News Archive
Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.
New research suggests that sedating patients before a nerve block needed to diagnose or treat chronic pain increases costs, risks and unnecessary surgeries, and sedation does nothing to increase patient satisfaction or long-term pain control.
Children with a birth weight under 2.5 kilos stand at risk of becoming underweight and can experience cognitive difficulties as well as diabetes and cardiovascular disease later in life.
Novoheart, a global stem cell biotechnology company, is pleased to announce a collaboration with global biopharmaceutical company AstraZeneca, in an effort to develop the world's first human-specific in vitro, functional model of heart failure with preserved ejection fraction (HFpEF), a common condition especially among the elderly and in women, with the reported prevalence approaching 10% in women over the age of 80 years.
Scientists from the Institute for Research in Biomedicine (IRB Barcelona), the Life Sciences Programme at the Barcelona Supercomputing Center (BSC) and the National Institute for Bioinformatics (INB) have published a provisional "atlas" of the dynamic behaviour of proteins in the prestigious scientific journal, Proceedings of the National Academy of Sciences.
› Verified 4 days ago
Dr. Vincent William Savarese, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 703 E Main St, Moorestown, NJ 08057 Phone: 856-727-0900 | |
James W Lee, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 350 Young Ave Ste 200, Moorestown, NJ 08057 Phone: 609-702-1900 Fax: 609-702-8456 | |
Dr. Morton Hoffman, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 5 Shelter Rock Place, Moorestown, NJ 08057 Phone: 856-234-1406 Fax: 856-234-0918 | |
Dr. Samuel M Ventrella, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 728 Marne Hwy Ste 200a, Moorestown, NJ 08057 Phone: 856-291-8855 Fax: 856-291-8844 | |
Maurice J Cairoli, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 350 Young Ave Ste 200, Moorestown, NJ 08057 Phone: 609-702-1900 Fax: 609-702-8456 | |
Stephen G Wallace, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 350 Young Ave Ste 200, Moorestown, NJ 08057 Phone: 609-702-1900 Fax: 609-702-8455 | |
Dr. Eduard Koman, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 728 Marne Hwy Ste 200a, Moorestown, NJ 08057 Phone: 856-291-8855 Fax: 856-291-8844 |